Retrospective analysis and clinical performance of BD MAX enteric pathogen testing with a focus on reliable identification of vibrio species in stool samples.

Infectious diarrhea is a significant health concern, particularly for immunocompromised and pediatric patients. Traditional stool culture methods are labor-intensive and often lack sensitivity, prompting clinical laboratories to adopt PCR-based gastrointestinal pathogen panels (GIPPs). This study evaluated the BD MAX™ GIPP compared to traditional methods, focusing on the accuracy of the platform's automatic interpretations.